HbA1c, side-effects and weight when taking the participants preferred drug
SIDE EFFECT
There were marked differences in the glycaemic outcomes and side effect profiles in the groups of patients who preferred specific drugs (Of the 441 participants with at least one valid HbA1c, on final ranking, after being fed back their HbA1c results, 309 (70% [95% CI 66%,74%]) preferred the drug that resulted in the lowest HbA1c for them (On final ranking, 301/448 (67% [95% Ci 63%, 72%]) chose the drug with the lowest number of side effects for them (Weight was less of a deciding factor in patient choice, with pioglitazone associated with the highest weight on therapy, regardless of their preference (see 